- Prevalence and impact of extended-spectrum beta-lactamase production on clinical outcomes in cancer patients with Enterobacter species bacteremia
-
Kim SJ, Park KH, Chung JW, Sung H, Choi SH, Choi SH
- KMID: 1794629
- Korean J Intern Med.
- 2014 Sep;29(5):637-646.
- doi: 10.3904/kjim.2014.29.5.637
BACKGROUND/AIMS: We examined the prevalence of extended-spectrum beta-lactamase (ESBL) production and the impact of ESBL on clinical outcomes in cancer patients with Enterobacter spp. bacteremia. METHODS: Using prospective cohort data on... -
- CITED
-
- Close
- SHARE
-
- Close
